These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3962)

  • 1. Symposium on hypertension: Part II. Renin profiling and drug therapy, childhood hypertension, prorenin, the physiology of renin secretion. Introduction.
    Laragh JH
    Am J Cardiol; 1976 Mar; 37(4):635-6. PubMed ID: 3962
    [No Abstract]   [Full Text] [Related]  

  • 2. Prorenin and beta-blockade in hypertension.
    McKenna F; Davison AM
    Proc Eur Dial Transplant Assoc; 1983; 20():566-71. PubMed ID: 6140678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-adrenoceptor activation stimulates, and phosphodiesterase inhibition potentiates, placental prorenin synthesis and release.
    Downing GJ; Poisner R; Poisner AM
    J Clin Endocrinol Metab; 1994 Jan; 78(1):41-7. PubMed ID: 7904614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
    Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH
    Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-adrenoceptor activation-induced placental prorenin secretion is mediated by increased renin messenger RNA and protein synthesis.
    Downing GJ; Yan B; Poisner AM
    Mol Pharmacol; 1997 Feb; 51(2):201-8. PubMed ID: 9203624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin and beta-blockade: prorenin and aldosterone may explain the controversy.
    McKenna F; Davison AM
    Clin Nephrol; 1986 Mar; 25(3):149-54. PubMed ID: 2869848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extraction of plasma prorenin by human heart.
    Skinner SL; Thatcher RL; Whitworth JA; Horowitz JD
    Lancet; 1986 May; 1(8488):995-7. PubMed ID: 2871332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclical secretion of prorenin during the menstrual cycle: synchronization with luteinizing hormone and progesterone.
    Sealey JE; Atlas SA; Glorioso N; Manapat H; Laragh JH
    Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8705-9. PubMed ID: 3909151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue activity of circulating prorenin.
    Prescott G; Silversides DW; Reudelhuber TL
    Am J Hypertens; 2002 Mar; 15(3):280-5. PubMed ID: 11939621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrogen and potassium regulation of (pro)renin processing and secretion.
    King JA; Fray JC
    Am J Physiol; 1994 Jul; 267(1 Pt 2):F1-12. PubMed ID: 8048549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of completely inactive plasma prorenin and its activation by kallikreins. A possible new link between renin and kallikrein.
    Yokosawa N; Takahashi N; Inagami T; Page DL
    Biochim Biophys Acta; 1979 Aug; 569(2):211-9. PubMed ID: 476126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcellular dysregulation of renin and prorenin expression in Black essential and diabetic hypertensives.
    Fray JC
    Ethn Dis; 1992; 2(2):142-57. PubMed ID: 1467752
    [No Abstract]   [Full Text] [Related]  

  • 13. Renin-guided treatment of hypertension: time for action.
    Furberg CD
    Am J Hypertens; 2010 Sep; 23(9):929-30. PubMed ID: 20733565
    [No Abstract]   [Full Text] [Related]  

  • 14. Prorenin and renin as separate mediators of tissue and circulating systems.
    Sealey JE; Rubattu S
    Am J Hypertens; 1989 May; 2(5 Pt 1):358-66. PubMed ID: 2655661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction to part II of the hypertension symposium. Prorenin, renal hypertension; diuretics and hyperlipidemia; angiotensin receptors and blocking drugs; a new treatment system.
    Laragh JH
    Am J Med; 1976 Nov; 61(5):721-4. PubMed ID: 10726
    [No Abstract]   [Full Text] [Related]  

  • 16. [Essential hypertension: adrenergic control system, renin-angiotensin effector axis, kidney and age].
    Bühler FR
    Schweiz Med Wochenschr; 1976 Dec; 106(50):1798-806. PubMed ID: 13490
    [No Abstract]   [Full Text] [Related]  

  • 17. Activation and function of prorenin: different viewpoints. Satellite symposium, 13th scientific meeting of the International Society of Hypertension, Montreal, Canada, June 22, 1990.
    Can J Physiol Pharmacol; 1991 Sep; 69(9):1307-97. PubMed ID: 1756429
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyponatremic hypertensive syndrome and massive proteinuria in a patient with renin-producing leiomyosarcoma.
    Misiani R; Sonzogni A; Poletti EM; Cassinelli G; Gualandris L; Pericotti S; Ghislandi R; Agazzi R; Belair MF; Bruneval P
    Am J Kidney Dis; 1994 Jul; 24(1):83-8. PubMed ID: 8023829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated concentrations of prorenin and renin in amniotic fluid of women with chorioamnionitis.
    Mitchell MD; Hunter C; Dudley DJ; Varner MW
    J Perinatol; 1997; 17(2):116-8. PubMed ID: 9134509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prorenin in high concentrations in human ovarian follicular fluid.
    Glorioso N; Atlas SA; Laragh JH; Jewelewicz R; Sealey JE
    Science; 1986 Sep; 233(4771):1422-4. PubMed ID: 3529392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.